234 related articles for article (PubMed ID: 19549593)
41. Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.
Cheng SY
Trends Endocrinol Metab; 2005; 16(4):176-82. PubMed ID: 15860414
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
43. Thyroid Hormone Receptors: Several Players for One Hormone and Multiple Functions.
Samarut J; Plateroti M
Methods Mol Biol; 2018; 1801():1-8. PubMed ID: 29892811
[TBL] [Abstract][Full Text] [Related]
44. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone.
Kaneshige M; Kaneshige K; Zhu X; Dace A; Garrett L; Carter TA; Kazlauskaite R; Pankratz DG; Wynshaw-Boris A; Refetoff S; Weintraub B; Willingham MC; Barlow C; Cheng S
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13209-14. PubMed ID: 11069286
[TBL] [Abstract][Full Text] [Related]
45. The pituitary tumor transforming gene in thyroid cancer.
Lewy GD; Sharma N; Seed RI; Smith VE; Boelaert K; McCabe CJ
J Endocrinol Invest; 2012 Apr; 35(4):425-33. PubMed ID: 22522436
[TBL] [Abstract][Full Text] [Related]
46. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.
Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S
J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629
[TBL] [Abstract][Full Text] [Related]
47. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
48. Molecular aspects of thyroid hormone actions.
Cheng SY; Leonard JL; Davis PJ
Endocr Rev; 2010 Apr; 31(2):139-70. PubMed ID: 20051527
[TBL] [Abstract][Full Text] [Related]
49. New insights into regulation of lipid metabolism by thyroid hormone.
Zhu X; Cheng SY
Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):408-13. PubMed ID: 20644471
[TBL] [Abstract][Full Text] [Related]
50. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
[TBL] [Abstract][Full Text] [Related]
51. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function.
Forrest D; Hanebuth E; Smeyne RJ; Everds N; Stewart CL; Wehner JM; Curran T
EMBO J; 1996 Jun; 15(12):3006-15. PubMed ID: 8670802
[TBL] [Abstract][Full Text] [Related]
52. PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.
Kato Y; Ying H; Zhao L; Furuya F; Araki O; Willingham MC; Cheng SY
Oncogene; 2006 May; 25(19):2736-47. PubMed ID: 16314832
[TBL] [Abstract][Full Text] [Related]
53. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract][Full Text] [Related]
54. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice.
O'Shea PJ; Williams GR
J Endocrinol; 2002 Dec; 175(3):553-70. PubMed ID: 12475367
[TBL] [Abstract][Full Text] [Related]
55. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
Ying H; Willingham MC; Cheng SY
Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
[TBL] [Abstract][Full Text] [Related]
56. Thyroid hormone receptors and resistance to thyroid hormone disorders.
Ortiga-Carvalho TM; Sidhaye AR; Wondisford FE
Nat Rev Endocrinol; 2014 Oct; 10(10):582-91. PubMed ID: 25135573
[TBL] [Abstract][Full Text] [Related]
57. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.
Wan W; Farboud B; Privalsky ML
Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373
[TBL] [Abstract][Full Text] [Related]
58. Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors.
Rusch A; Ng L; Goodyear R; Oliver D; Lisoukov I; Vennstrom B; Richardson G; Kelley MW; Forrest D
J Neurosci; 2001 Dec; 21(24):9792-800. PubMed ID: 11739587
[TBL] [Abstract][Full Text] [Related]
59. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
60. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
